Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersInternal Medicine Physician in Birmingham, AL
NPI: 1184712911Primary Practice Location
Summit Internal Medicine
3570 Grandview Pkwy, Birmingham, AL
Primary Employer
Summit Internal Medicine
summitinternalmedicine.com
HQ Phone
Get M.D. David's Phone NumberMobile
Get M.D. David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 357 | 762 |
| 2 | G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 272 | 272 |
| 3 | 71046X-ray of chest, 2 views | 178 | 198 |
| 4 | 83036Hemoglobin A1C level | 150 | 250 |
| 5 | 93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 126 | 131 |
Authors: Zhang, Wei, Glaze, Jeffrey H, Wynne, David
Journal: CEN Case Rep
Publication Date: 2018-02-01
Nesidioblastosis: an uncommon complication seen post Roux-en-Y gastric bypass.
Authors: Jacob Greenspan, Elizabeth Ennis
Journal: Endocrinol Diabetes Metab Case Rep
Publication Date: 2022-12-01
Amiodarone-Induced Epididymitis: A Case Report and Review of the Literature.
Authors: Lyon, Blake A, Wynne, David
Journal: Cureus
Publication Date: 2024-06-21
Lead Sponsor: Exact Sciences Corporation
Intervention / Treatment: DIAGNOSTIC_TEST: FIT test, PROCEDURE: Colonoscopy, DIAGNOSTIC_TEST: mt-sDNA 2.0 screening test
Lead Sponsor: Exact Sciences Corporation
Intervention / Treatment: OTHER: Blood Sample Collection
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo IV, DRUG: Vedolizumab IV, DRUG: Placebo SC, DRUG: Mirikizumab SC, DRUG: Mirikizumab IV
